• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV770T
Medical Device Problem Codes Mechanical Problem (1384); Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 10/26/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Visual inspection: visual inspection showed the following: prosa® with deformations and scratches, progav® with deformations, control reservoir with external deposits.Permeability test: the investigation has shown that the prosa® is not permeable, while the progav® and the control reservoir are permeable.Adjustment test: both valves could be adjusted in all pressure ranges, however, this could be done without applying any force.The brake function is no longer given and the pressure stages cannot be held.Braking force and brake function test: the function of the brake could no longer be checked on either valve.It is therefore not possible to measure the braking force.Computer controlled test: to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.A test bench measurement of the prosa® and progav® is not meaningful due to the detected failure of the brake function, as the valves cannot maintain the set opening pressure in the event of a defective brake.Internal inspection : after dismantling of the valve, deposits were found in prosa® und progav 2.0.Results: the test results show a blockage on the prosa® as well as a deformed housing surface and a failure of the brake function on both valves.The cause of the blockage may be the deposits found, the cause of the failure of the brake function may be the deformations of the housing surfaces found.Deposits caused by substances naturally present in the body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of protein can compromise the integrity of the valve.High pressure exerted, for example by the adjustment instrument or a fall or blow to the patient's head, can compromise the integrity of the valve.Significant outside pressure, for example by too much force from the progav® adjustment tool or by a fall or impact to the head of the patient, can compromise the integrity of the valve.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event or Problem Description
It was reported that a prosa shunt system with progav (part # fv770t) was implanted during a procedure performed on (b)(6) 2016.According to the complainant, the shunt system was believed to be operated in overdrainage and not adjustable.The patient underwent a revision procedure performed on (b)(6) 2022.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 28 years.Height: 180 centimeters (cm).Weight: 90 kilograms (kg).Gender: male.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key15849754
Report Number3004721439-2022-00352
Device Sequence Number6429126
Product Code JXG
UDI-Device Identifier04041906135553
UDI-Public4041906135553
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K120559
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2022
Serviced by Third Party (Y/N)Y
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/12/2020
Device Model NumberFV770T
Device Catalogue NumberFV770T
Device Lot Number20027232
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/26/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/26/2022
Initial Report FDA Received Date11/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/13/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age28 YR
Patient SexMale
Patient Weight90 KG
-
-